BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15078100)

  • 21. Structure, function, and mechanism of cytosolic quinone reductases.
    Bianchet MA; Erdemli SB; Amzel LM
    Vitam Horm; 2008; 78():63-84. PubMed ID: 18374190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylenetetrahydrofolate reductase. Steady state and rapid reaction studies on the NADPH-methylenetetrahydrofolate, NADPH-menadione, and methyltetrahydrofolate-menadione oxidoreductase activities of the enzyme.
    Vanoni MA; Ballou DP; Matthews RG
    J Biol Chem; 1983 Oct; 258(19):11510-4. PubMed ID: 6352699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents.
    Andricopulo AD; Akoachere MB; Krogh R; Nickel C; McLeish MJ; Kenyon GL; Arscott LD; Williams CH; Davioud-Charvet E; Becker K
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2283-92. PubMed ID: 16458512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis.
    Boutin JA; Saunier C; Guenin SP; Berger S; Moulharat N; Gohier A; Delagrange P; Cogé F; Ferry G
    Arch Biochem Biophys; 2008 Sep; 477(1):12-9. PubMed ID: 18502195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties.
    Megarity CF; Gill JR; Caraher MC; Stratford IJ; Nolan KA; Timson DJ
    FEBS Lett; 2014 May; 588(9):1666-72. PubMed ID: 24631540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic differences in inhibition of ubiquinol cytochrome c reductase by the proximal Qo-site inhibitors famoxadone and methoxyacrylate stilbene.
    Pember SO; Fleck LC; Moberg WK; Walker MP
    Arch Biochem Biophys; 2005 Mar; 435(2):280-90. PubMed ID: 15708371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of antimalarials chloroquine, quinine, primaquine and mepacrine on the evolution of Ehrlich ascites tumour.
    Castelli M; Baggio G; Ruberto AI; Tampieri A; Tartoni PL; Rossi T; Bossa MR; Galatulas I
    Anticancer Res; 1996; 16(5A):2673-5. PubMed ID: 8917368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox-dependent sodium binding by the Na(+)-translocating NADH:quinone oxidoreductase from Vibrio harveyi.
    Bogachev AV; Bertsova YV; Aitio O; Permi P; Verkhovsky MI
    Biochemistry; 2007 Sep; 46(35):10186-91. PubMed ID: 17696408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibition.
    Dufour M; Yan C; Siegel D; Colucci MA; Jenner M; Oldham NJ; Gomez J; Reigan P; Li Y; De Matteis CI; Ross D; Moody CJ
    Chembiochem; 2011 May; 12(8):1203-8. PubMed ID: 21506232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance.
    Tan DX; Manchester LC; Terron MP; Flores LJ; Tamura H; Reiter RJ
    J Pineal Res; 2007 Nov; 43(4):317-20. PubMed ID: 17910598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic and structural studies on the catalytic role of the aspartic acid residue conserved in copper amine oxidase.
    Chiu YC; Okajima T; Murakawa T; Uchida M; Taki M; Hirota S; Kim M; Yamaguchi H; Kawano Y; Kamiya N; Kuroda S; Hayashi H; Yamamoto Y; Tanizawa K
    Biochemistry; 2006 Apr; 45(13):4105-20. PubMed ID: 16566584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The quinone-binding site of Acidithiobacillus ferrooxidans sulfide: quinone oxidoreductase controls both sulfide oxidation and quinone reduction.
    Zhang Y; Qadri A; Weiner JH
    Biochem Cell Biol; 2016 Apr; 94(2):159-66. PubMed ID: 26914540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
    Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model.
    Martirosyan AR; Rahim-Bata R; Freeman AB; Clarke CD; Howard RL; Strobl JS
    Biochem Pharmacol; 2004 Nov; 68(9):1729-38. PubMed ID: 15450938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.
    Reddy PV; Jensen KC; Mesecar AD; Fanwick PE; Cushman M
    J Med Chem; 2012 Jan; 55(1):367-77. PubMed ID: 22206487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of anti-malarial drugs on human natural killer cells in vitro.
    Ferrante A; Goh DH
    Parasite Immunol; 1984 Nov; 6(6):571-80. PubMed ID: 6335236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.
    Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ
    Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.
    St John SE; Jensen KC; Kang S; Chen Y; Calamini B; Mesecar AD; Lipton MA
    Bioorg Med Chem; 2013 Oct; 21(19):6022-37. PubMed ID: 23953689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theoretical determination of the redox potentials of NRH:quinone oxidoreductase 2 using quantum mechanical/molecular mechanical simulations.
    Rauschnot JC; Yang C; Yang V; Bhattacharyya S
    J Phys Chem B; 2009 Jun; 113(23):8149-57. PubMed ID: 19445526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fluoro analogue of the menadione derivative 6-[2'-(3'-methyl)-1',4'-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme.
    Bauer H; Fritz-Wolf K; Winzer A; Kühner S; Little S; Yardley V; Vezin H; Palfey B; Schirmer RH; Davioud-Charvet E
    J Am Chem Soc; 2006 Aug; 128(33):10784-94. PubMed ID: 16910673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.